Ethnobotany as a pharmacological research tool and recent developments in CNS-active natural products from ethnobotanical sources

Pharmacology and Therapeutics

Volumn 123, Issue 2, 2009, Pages 239-254

  McClatchey, Will C ^a   Mahady, Gail B ^b   Bennett, Bradley C ^c   Shiels, Laura ^a   Savo, Valentina ^d  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^d ROMA TRE UNIVERSITY   (Italy)

Author keywords

Hoodia; Hypericum perforatum; Methylxanthines; Piper methysticum; Salvia divinorum

Indexed keywords

ALCOHOL; ARECOLINE; ATROPINE; BILOBALIDE; CAFFEINE; CATHINONE; COCAINE; CODEINE; EPHEDRINE; ERGOTAMINE; GINKGOLIDE; HARMALINE; HARMINE; HYOSCYAMINE; IBOGAINE; KAWAIN; LYSERGIC ACID; MESCALINE; METHYSTICIN; MITRAGYNINE; MORPHINE; MUSCARINE; MUSCIMOL; N,N DIMETHYLTRYPTAMINE; NATURAL PRODUCT; PHYSOSTIGMINE; PILOCARPINE; PSILOCIN; RESERPINE; UNINDEXED DRUG;

ATROPA BELLADONNA; BANISTERIOPSIS; BARLEY; BETEL NUT; CACAO; CATHA EDULIS; CENTRAL NERVOUS SYSTEM; CLAVICEPS PURPUREA; COFFEE; COLA; CULTURAL FACTOR; DATURA STRAMONIUM; DRUG ACTIVITY; DRUG RESEARCH; DUBOISIA; EPHEDRA SINICA; ERYTHROXYLACEAE; ETHICS; ETHNOBOTANY; GINKGO BILOBA; GRAPE; HEALTH CARE; HYOSCYAMUS; ILEX; IPOMOEA; MANDRAGORA; MEDICINAL PLANT; MITRAGYNA; NONHUMAN; PAPAVER SOMNIFERUM; PASSION FRUIT; PAULLINIA; PEGANUM HARMALA; PHYSOSTIGMA; PHYTOCHEMISTRY; PILOCARPUS; PIPER METHYSTICUM; PLANT EVOLUTION; PRIORITY JOURNAL; RAUWOLFIA; REVIEW; TEA; TOBACCO;

BIOLOGICAL PRODUCTS; CENTRAL NERVOUS SYSTEM AGENTS; ETHNOBOTANY; PLANTS, MEDICINAL; RESEARCH;

EID: 67349179949     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2009.04.002     Document Type: Review

References (161)

1. Abbott I.A. Lā`au Hawai`i: Traditional Hawaiian Uses Of Plants (1992), B.P. Bishop Museum Press, Honolulu, HI
2. Abourashed E.A., Koetter U., and Brattström A. In vitro binding experiments with Valeriean, Hops and their fixed combination extract (Ze91019) to selected central nervous system receptors. Phytomedicine 11 (2004) 633-638
3. Alland A. Adaptation in Cultural Evolution: An Approach To Medical Anthropology (1970), Columbia University Press, New York
4. Anonymous. Hoodia: lose weight without feeling hungry?. Consum Rep 71 (2006) 49
5. Bara A.I., and Barley E.A. Caffeine for asthma. Cochrane database of systematic reviews, issue 4. Art. no.: CD001112 (2001) 10.1002/14651858.CD001112
6. Beaubrun G., and Gray G.W. A review of herbal medicines for psychiatric disorders. Psychiatr Serv 51 9 (2000) 1130-1134
7. Bennett B.C., Baker M.A., and Gómez P. Ethnobotany of the Shuar of eastern Ecuador. Adv Econ Bot 14 (2002) 1-299
8. Bent S., Padula A., Moore D., Patterson M., and Mehling W. Valeriain for sleep: a systematic review and meta-analysis. Am J Med 119 (2006) 1005-1012
9. Bishnoi M., Chopra K., and Kulkarni S.K. Theophylline, adenosine receptor antagonist prevents behavioral, biochemical and neurochemical changes associated with an animal model of tardive dyskinesia. Pharmacol Rep 59 2 (2007) 181-191
10. Biswas S.S., Donovan C.L., Forbess J.M., Royal S.H., and Landolfo K.P. Valve replacement for appetite suppressant-induced valvular heart disease. Ann Thorac Surg 67 6 (1999) 1819-1822
11. Blumenthal M., Goldberg A., and Brinckmann J. The Complete German Commission E Monographs: therapeutic guide to herbal medicines. American Botanical Council (2000), Integrative Medicine Communications, Austin, TX
12. Bombardelli E., and Morazzoni P. Hypericum perforatum. Fitoterapia 66 (1995) 43-68
13. Brekhman I.I., and Dardymov I.V. New substances of plant origin which increase nonspecific resistance. Annu Rev Pharmacol 9 (1969) 419-430
14. Brown R.P., Gerbarg P.L., and Ramazanov Z. Rhodiola rosea: a phytomedicinal overview. HerbalGram 56 (2002) 40-52
15. Browner C.H., Ortiz de Montellano B.R., and Rubel A.J. A methodology for cross-cultural ethnomedical research. Curr Anthropol 29 5 (1988) 681-702
16. Brunton L., Lazo J., and Parker K. Goodman & Gilman's The Pharmacological Basis of Therapeutics. (11th ed.). (2005), McGraw-Hill, New York
17. Bruyns P. A Revision of Hoodia and Lavrania (Asclepiadaceae-Stapelieae). Bot Jahrb Syst Pflanzengesch Pflanzengeogr 115 2 (1993) 145-270
18. Butterweck V., and Schmidt M. St. John's wort: role of active compounds for its mechanism of action and efficacy. Wien Med Wochenschr 157 (2007) 356-361
19. Cabrelle A., Dell'Aica I., Melchiori L., Carraro S., Brunetta E., Niero R., et al. Hyperforin down-regulates effector function of activated T-lymphocytes and shows efficacy against Th1-triggered CNS inflammatory-demyelinating disease. J Leukoc Biol 83 (2008) 212-219
20. Calixto J.B., Beirith A., Ferreira J., Santos A.R.S., Filho V.C., and Yunes R.A. Naturally occurring antinociceptive substances from plants. Phytother Res 14 (2000) 401-418
21. Carlini E.A. Plants and the central nervous system. Pharmacol Biochem Behav 75 (2003) 501-512
22. Carrillo J.A., and Benitez J. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin Pharmacokinet 39 2 (2000) 127-153
23. Cauli O., and Morelli M. Caffeine and the dopaminergic system. Behav Pharmacol 16 2 (2005) 63-77
24. Chevallier A. The Encyclopedia of Medicinal Plants (1996), DK, New York
25. Choudhuri S., and Valerio Jr. L.G. Usefulness of studies on the molecular mechanism of action of herbals/botanicals: the case of St. John's wort. J Biochem Mol Toxicol 19 (2005) 1-11
26. Clouatre D.L. Kava kava: examining new reports of toxicity. Toxicol Lett 150 (2004) 85-96
27. Convention on Biological Diversity. Conventions of the United Nations Environment Program (1992), United Nations, New York
28. Cox P.A. The ethnobotanical approach to drug discovery: strengths and limitations. Ethnobotany and the search for new drugs. Ciba Foundation Symposium Vol. 185 (1994), Wiley, Chichester 25-41
29. Cox P.A. Linnaeus: the unfinished journey. Plant Talk 16 January (1999) 33-36
30. Cunningham A.B. People's science: southern African ethnobotany in global perspective. S Afr J Bot 74 2 (2008) 357
31. Dall'Acqua S., and Innocenti G. Steroidal glycosides from Hoodia gordonii. Steroids 72 6-7 (2007) 559-568
32. Daly J.W. Alkylxanthines as research tools. J Auton Nerv Syst 81 1-3 (2000) 44-52
33. Daly J.W. Caffeine analogs: biomedical impact. Cell Mol Life Sci 64 (2007) 2153-2169
34. Daly J.W., Butts-Lamb P., and Padgett W. Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines. Cell Mol Neurobiol 3 (1983) 69-80
35. Darbinyan V., Aslanyan G., Amroyan E., Gabrielyan E., Malmström C., and Panossian A. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Nord J Psychiatr 61 (2007) 343-348
36. Debry G. Coffee and Health (1994), John Libbey Eurotext, France
37. Dietz B.M., Mahady G.B., Pauli G.F., and Farnsworth N.R. Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Mol Brain Res 138 (2005) 191-197
38. Do Q.-T., and Bernard P. Reverse pharmacognosy: a new concept for accelerating natural drug discovery. In: Khan M.T.H., and Ather A. (Eds). Lead molecules from natural products. Advances in phytomedicine series Vol. 2 (2006), Elsevier, The Nederlands 1-19
39. Dragull K., Yoshida W.Y., and Tang C.S. Piperidine alkaloids from Piper methysticum. Phytochemistry 63 (2003) 193-198
40. Edwards A., and Bennett B.C. Diversity of methylxanthine content in Ilex cassine L. and Ilex vomitoria Ait.: assessing sources of the North American stimulant cassina. Economic Botany 59 (2005) 275-285
41. Eisenberg L. Disease and illness: distinctions between professional and popular ideas of sickness. Cult Med Psychiatry 1 (1977) 9-23
42. Estabrook G.F. Neither wild nor planted: essential role of giesta (Cytisus, Fabaceae) in traditional agricutlure of Beira Alta, Portugal. Econ Bot 60 (2006) 307-320
43. Etkin N. Anthropological methods in ethnopharmacology. J Ethnopharmacol 38 (1993) 93-104
44. Fairbanks C.H. The function of black drink among the creeks. In: Hudson C.M. (Ed). Black drink: a native American tea (1979), University of Georgia Press, Athens, GA, USA 120-149
45. German Commission E Monographs. The Complete German Commission E Monographs, Therapeutic Guide to Herbal Medicines. (1st ed.). (1998), Integrative Medicine Communications, Newton, MA
46. Giorgetti M., Negri G., and Redrigues E. Brazilian plants with possible action on the central nervous system - a study of historical sources from the 16th to 19th century. J Ethnopharmacol 109 (2007) 338-347
47. Gordon Jr. R.G. Ethnologue: Languages of the World. (15th ed.). (2005), SIL International, Dallas, TX
48. Green A.R., Carrillo J.E., and Betancourt J.R. Why the disease-based model of medicine fails our patients. West J Med 176 (2002) 141-143
49. Greenberg J.A., Axen K.V., Schnol L.R., and Boozer C.N. Coffee, tea and diabetes: the role of weight loss and caffeine. Int J Obes 29 (2005) 1121-1129
50. Greenberg J.A., Boozer C.N., and Geliebter A. Coffee, diabetes, and weight control. Am J Clin Nutr 84 (2006) 682-693
51. Gu L., Gonzalez F.J., Kalow W., and Tang B.K. Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics 2 2 (1992) 73-77
52. Gulati K., Ray A., Pal G., and Vijayan V.K. Possible role of free radicals in theophylline-induced seizures in mice. Pharmacol Biochem Behav 82 1 (2005) 241-245
53. Gupta S.P. Quantitative structure-activity relationships of cardiotonic agents. Prog Drug Res 55 (2000) 235-282
54. Hackman R.M., Havel P.J., Schwartz H.J., Rutledge J.C., Watnik M.R., Noceti E.M., et al. Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial. Int J Obes 30 (2006) 1545-1556
55. Hahn G. Hypericum perforatum (St. John's wort) - a medicinal herb used in antiquity and still of interest today. J Naturopath Med 3 (1992) 94-96
56. Hahn R.A. Sickness and Healing: An Anthropological Perspective (1995), Yale University Press, New Haven, CT
57. Hakkinen, J., Horak, R.M., Maharaj, V. (2004). US Patent No. US 6,808,723 B2.
58. Halpern J.H. Hallucinogens and dissociative agents naturally growing in the United States. Pharmacol Ther 102 (2004) 131-138
59. Halpern R., and Sewell A. Hallucinogenic botanicals of America: a growing need for focused drug education and research. Life Sci 78 (2005) 519-526
60. Hänsel R. Characterization and physiological activity of some kava constituents. Pac Sci 22 (1968) 293-313
61. Harding W.W., Schmidt M., Tidgewell K., Kannan P., Holden K.G., Dersch C.M., et al. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: selective modification of the furan ring. Bioorg Med Chem Lett 16 (2006) 3170-3174
62. Harris M. Cultural Matierialism: The Struggle for a Science of Culture (1979), Vintage, New York
63. Harrison D.K. When Languages Die (2007), Oxford University Press, Oxford, UK
64. Hobbs C. St. John's wort, Hypericum perforatum L. HerbalGram 18 (1989) 24-33
65. Holden K.G., Tidgewell K., Marquam A., Rothman R.B., Navarro H., and Prisinzan T.E. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: exploration of the 1-position. Bioorg Med Chem Lett 17 (2007) 6111-6115
66. Houghton P.J. The scientific basis for the reputed activity of valerian. J Pharm Pharmacol 51 (1999) 505-512
67. Hudson C.M. Black Drink: A Native American Tea (1979), University of Georgia Press, Athens, GA, USA
68. Ito K., Lim S., Caramori G., Cosio B., Chung K.F., Adcock I.M., et al. A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression. PNAS 99 (2005) 8921-8926
69. Kato M., Mizuno K., Crozier A., Fujimura T., and Ashihara H. Plant biotechnology: caffeine synthase gene from tea leaves. Nature 406 (2000) 956-957
70. Katzung B.G. Basic and Clinical Pharmacology. (10th ed.). (2006), McGraw-Hill, New York
71. Khom S., Baburin I., Timin E., Hohaus A., Trauner G., Kopp B., et al. Valerenic acid potentiates and inhibits GABAA receptors: molecular mechanism and subunit specificity. Neuropharmacology 53 (2007) 178-187
72. Kitagawa M., Houzen H., and Tashiro K. Effects of caffeine on the freezing of gait in Parkinson's disease. Mov Disord 22 5 (2007) 710-712
73. Kren V., and Martinkova L. Glycosides in medicine: the role of glycosidic residue in biological activity. Curr Med Chem 8 (2001) 1303-1328
74. Kroeze W.K., Sheffler D.J., and Roth B.L. G-protein coupled receptors at a glance. J Cell Sci 116 (2003) 4867-4869
75. Kumar S. India wins battle with USA over turmeric patent. Lancet 350 (1997) 724
76. Kumar V. Potential medicinal plants for CNS disorders: an overview. Phytother Res 20 12 (2006) 1023-1035
77. Lange J.E., Reed M.B., Ketchie J.M., and Clapp J.D. College student use of Salvia divinorum. Drug Alcohol Depend 94 (2008) 263-266
78. Lebot V., Merlin M., and Lindstrom L. Kava, the Pacific Drug (1992), Yale University Press, New Haven
79. Lee D.Y.W., He M., Liu-Chen L.-Y., Wang Y., Li J.-G., Xu W., et al. Synthesis and in vitro pharmacological studies of new C(4)-modified salvinorin A analogues. Bioorg Med Chem Lett 16 (2006) 5498-5502
80. Lee R.A., and Balick M.J. Indigenous use of Hoodia gordonii and appetite suppression. J Sci Heal 3 4 (2007) 404-406
81. Levin B.E., and Routh V.H. Role of the brain in energy balance and obesity. Am J Physiol 271 3 (1996) 491-500
82. Lewis W.H., Kennelly E.J., Bass G.N., Wedner H.J., Elvin-Lewis M.P., and Fast D. Ritualistic use of the holly Ilex guayusa by Amazonian Jívaro Indians. J Ethnopharmacol 33 1-2 (1991) 25-30
83. Mabberley D.J. The Plant Book: A Portable Dictionary of the Vascular Plants. (3rd ed.). (2008), Cambridge University Press, Cambridge, UK
84. MacLean D.B., and Luo L.G. Increased ATP content/production in the hypothalamus may be a signal for energy-sensing of satiety: studies of the anorectic mechanism of a plant steroidal glycoside. Brain Res 1020 (2004) 1-11
85. Madabushi R., Frank B., Drewelow B., Derendorf H., and Butterweck V. Hyperforin in St. John's wort drug interactions. Eur J Clin Pharmacol 62 (2006) 225-233
86. Mahady G.B., Fong H.H.S., and Farnsworth N.R. WHO Monographs of Selected Medicinal Plants. Volume II (2001), Herba Hyperici, World Health Organization, Geneva, Switzerland
87. Mantle D., Pickering A.T., and Perry E.K. Medicinal plant extracts for the treatment of dementia: a review of their pharmacology, efficacy and tolerability. CNS Drugs 13 (2000) 201-213
88. Marloth R. The Flora of South Africa with Synopsis of the South African Genera of Phanerogamous Plants. (Vol. III) (1932), Wheldon and Wesley, London
89. Mashelkar R.A., General D., and Bhawan A. Intellectual property rights and the Third World. Curr Sci 81 8 (2001) 955-965
90. Matsumoto K., Hatori Y., Murayama T., Tashima K., Wongseripipatana S., Misawa K., et al. Involvement of μ-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa. Eur J Pharmacol 549 (2006) 63-70
91. Matsumoto K., Horie S., Ishikawa H., Takayama H., Aimi N., Ponglux D., et al. Antinociceptive effect of 7-hydroxymitragynine in mice: discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa. Life Sci 74 (2004) 2143-2155
92. McClatchey W. Bioprospecting and ethnobotany research. Ethnobot Res Appl 3 (2005) 189-190
93. McCurdy C.R., and Scully S.S. Analgesic substances derived from natural products (natureceuticals). Life Sci 78 (2005) 476-484
94. McKenna D.J. Clinical investigations of the therapeutic potential of ayuhuasca: rationale and regulatory challenges. Pharmacol Ther 102 (2004) 111-129
95. Merrill W.L. The beloved tree. In: Hudson C.M. (Ed). Black drink: a native American tea (1979), University of Georgia Press, Athens, GA, USA 40-82
96. Milioli E.M., Cologni P., Santos C.C., Marcos T.D., Yunes V.M., Fernandes M.S., et al. Effect of acute administration of hydroalcohol extract of Ilex paraguariensis St Hilaire (Aquifoliaceae) in animal models of Parkinson's disease. Phytother Res 21 8 (2007) 771-776
97. Morsy S. Political economy in medical anthropology. In: Johnson T.M., and Sargent C.F. (Eds). Medical anthropology: contemporary theory and method (1990), Praeger, NY 26-46
98. Mukherjee P.K., Suresh B., and Verpoorte R. CNS active potentials of some Hypericum species of India. Phytomedicine 8 (2001) 331-337
99. Murch S., Cox P., and Banack S. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam. Proc Natl Acad Sci U S A 101 (2004) 12228-12231
100. Murdock G.P. Theories of Illness: A World Survey (1980), University of Pittsburgh Press, Pittsburgh, PA
101. Myers N., Mittermeier R.A., Mittermeier C.G., Da Fonseca G.A.B., and Kent J. Biodiversity hotspots for conservation priorities. Nature 403 (2000) 853-858
102. Nahrstedt A., and Butterweck V. Biologically active and other chemical constituents of the herb of Hypericum perforatum L. Pharmacopsychiatry 30 (1997) 129-134
103. Napoleon, K. (2004). He Kālailina I ka Limu ma ka Lā`au Lapa`au: He nīnauele me hulu kupuna Henry Allen Auwae. M.S. Thesis. Honolulu: University of Hawai`i.
104. Nehlig A., Daval J.L., and Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev 17 2 (1992) 139-170
105. Nerurkar P.V., Dragull K., and Tang C.S. In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones. Toxicol Sci 79 (2004) 106-111
106. Nettle D., and Romaine S. Vanishing Voices: The Extinction of the World's Languages (2000), Oxford University Press, Oxford, UK
107. Norman D., Bardwell W.A., Loredo J.S., Ancoli-Israel S., Heaton R.K., and Dimsdale J.E. Caffeine intake is independently associated with neuropsychological performance in patients with obstructive sleep apnea. Sleep Breath 12 3 (2008) 199-205
108. O'Connor K.A., and Roth B.L. Screening the receptorome for plant-based psychoactive compounds. Life Sci 78 (2005) 506-511
109. Ortega A., Blount J.F., and Manchand P.S. Salvinorin, a new trans-neoclerodane diterpene from Salvia divinorum (Labiatae). J Chem Soc Perkins Trans 1 (1982) 2505-2508
110. Osbaldeston T.A., and Wood R.P.A. Dioscorides, De Materia Medica (2000), IBIDIS Press, Johannesburg, South Africa (English translation)
111. Ostraff M. Limu: edible seaweed in Tonga, an ethnobotanical study. J Ethnobiol 26 (2006) 208-227
112. Pappe L. A Description of South African Forest Trees and Arborescent Shrubs Used for Technical and Economical Purposes. (2nd ed.). (1862), Ward and Co, Britain
113. Pardo Lozano R., Alvarez García Y., Barral Tafalla D., and Farré Albaladejo M. Caffeine: a nutrient, a drug or a drug of abuse. [Article in Spanish]. Adicciones 19 3 (2007) 225-238
114. Pawar R.S., Shukla Y.J., and Khan I.A. New calogenin glycosides from Hoodia gordonii. Steroids 72 13 (2007) 881-891
115. Pawar R.S., Shukla Y.J., Khan S.I., Avula B., and Khan I.A. New oxypregnane glycosides from appetite suppressant herbal supplement Hoodia gordonii. Steroids 72 6-7 (2007) 524-534
116. Perfumi M., and Mattioli L. Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice. Phytother Res 21 (2007) 37-43
117. Prance G.T., Aiona K., Balick M.J., Bennett B.C., Bridges K., Burney D.A., et al. Ethnobotany, the Science of survival: a declaration from Kaua`i. Econ Bot 61 (2007) 1-2
118. Prediger R.D., Pamplona F.A., Fernández D., and Takahashi R.N. Caffeine improves spatial learning deficits in an animal model of attention deficit hyperactivity disorder (ADHD) - the spontaneously hypertensive rat (SHR). Int J Neuropsychopharmacol 8 4 (2005) 583-594
119. Price D.M., and Kindscher K. One hundred years of Echinacea angustifolia harvest in the smoky hills of Kansas, USA. Econ Bot 61 (2007) 86-95
120. Rader J.I., Delmonte P., and Trucksess M.W. Recent studies on selected botanical dietary supplement ingredients. Anal Bioanal Chem 389 1 (2007) 27-35
121. Rappaport R. Pigs for the Ancestors: Ritual in the Ecology of a New Guinea People (1967), Yale University Press, New Haven, CT
122. Reiff M., O'Connor B., Kronenberg F., Balick M., and Lohr P. Ethnomedicine in the urban environment: Dominican healers in New York City. Human Organ 62 1 (2002) 12-26
123. Riedel W., Hogervorst E., Leboux R., Verhey F., van Praag H., and Jolles J. Caffeine attenuates scopolamine-induced memory impairment in humans. Psychopharmacology (Berlin) 122 2 (1995) 158-168
124. Ritchie K., Carrière I., de Mendonca A., Portet F., Dartigues J.F., Rouaud O., et al. The neuroprotective effects of caffeine: a prospective population study (the Three City Study). Neurology 69 6 (2007) 536-545
125. Robinson N.K. Studies in the genus Hypericum L. (Guttiferae). 2. Characters of the genus. Bull Br Mus Nat Hist Bot 8 (1981) 55-226
126. Rodrigues E., and Carlini E.A. Plants used by a Quilombola group in Brazil with potential central nervous system effects. Phytother Res 18 (2004) 748-753
127. Rosenthal M.J., Smith D., Yaguez L., Giampietro V., Kerr D., Bullmore E., et al. Caffeine restores regional brain activation in acute hypoglycaemia in healthy volunteers. Diabet Med 24 7 (2007) 720-727
128. Roth B.L., Baner K., Westkaemper R., Siebert D., Rice K.C., Steinberg S., et al. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci U S A 99 (2002) 11934-11939
129. Roth B.L., Lopez E., Beischel S., Westkaemper R.B., and Evans J.M. Screening the receptorome to discover the molecular targets for plant-derived psychoactive compounds: a novel approach for CNS drug discovery. Pharmacol Ther 102 (2004) 99-110
130. Rubin, I., Cawthorne, M., Bindra, J. (2006). US 7033616.
131. Russmann S., Lauterburg B.H., and Helbling A. Kava hepatotoxicity. Ann Intern Med 135 (2001) 68-69
132. Sahlins M. The Use and Abuse of Biology (1976), University of Michigan Press, Ann Arbor, MI
133. Salick J., Alcorn J., Anderson E., Asa C., Balee W., Balick M., et al. Intellectual imperatives in ethnobiology. National Science Foundation biocomplexity workshop report. Missouri Botanical Gardens, St. Louis (2003)
134. Sánchez-Mateo C.C., Prado B., and Rabanal R.M. Antidepressant effects of the methanol extract of several Hypericum species from the Canary Islands. J Ethnopharmacol 79 (2002) 119-127
135. Schellenberg R., Sauer S., Abourashed E.A., Koetter U., and Brattstrom A. The fixed combination of valerian and hops (Ze91019) acts via a central adenosine mechanism. Planta Med 70 (2004) 594-597
136. Schippmann U., Leaman D., and Cunningham A.B. Impact of cultivation and gathering of medicinal plants on biodiversity: global trends and issues. Biodiversity and the ecosystem approach in agriculture, forestry and fisheries (2002), Food and Agriculture Organization, Rome 1-21
137. Schmidt B., Roberts R.S., Davis P., Doyle L.W., Barrington K.J., Ohlsson A., et al. Caffeine for Apnea of Prematurity Trial Group. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 357 (2007) 1893-1902
138. Schmidt M., Nahrstedt A., and Lupke N.P. Piper methysticum (kava) under discussion: observations on quality, effectiveness and safety. Wien Med Wochenschr 152 (2002) 382-388
139. Schultes R.E., and Hofmann A. Plants of the Gods. Their Sacred, Healing and Hallucinogenic Powers (1992), Healing Arts Press, Rochester, Vermont
140. Shapiro R.E. Caffeine and headaches. Neurol Sci 28 2 (2007) S179-183
141. Singh Y.N., and Singh N.N. Therapeutic potential of kava in the treatment of anxiety disorders. CNS Drugs 16 (2002) 731-743
142. Smit H.J., Gaffan E.A., and Rogers P.J. Methylxanthines are the psycho-pharmacologically active constituents of chocolate. Psychopharmacology (Berlin) 176 (2004) 412-419
143. Smith R.M. Pipermethystine, a novel pyridine alkaloid. Tetrahedron 35 (1979) 437-439
144. Stoller R. Liver damage and kava extracts. Schweiz Artezg 81 (2000) 1335-1336
145. Taibi D.M., Landis C.A., Petry H., and Vitiello M.V. A systematic review of valerian as a sleep aid: safe but not effective. Sleep Med Rev 11 (2007) 207-230
146. Tulp O.L., Harbi N.A., Mihalov J., and DerMarderosian A. Effect of Hoodia plant on food intake and body weight in lean and obese LA/Ntul//-cp rats. FASEB J 15 (2001) A404
147. Turner N. Ethnobotany today in northwestern North America. In: Schultes R.E., and Von Reis S. (Eds). Ethnobotany: evolution of a discipline (1995), Dioscorides Press, Portland, OR 264-283
148. Turner N.J. Plant Technology of the First People of British Columbia: Including Neighboring Groups in Washington, Alberta and Alaska (1999), Royal British Columbia Museum Handbook Series, Victoria, BC
149. Usmani O.S., Belvisi M.G., Patel H.J., Crispino N., Birrell M.A., Korbonits M., et al. Theobromine inhibits sensory nerve activation and cough. FASEB J 19 2 (2005) 231-233
150. Valdes L.J., Butler W.M., Hatfield G.M., Paul A.G., and Koreeda M. Divinorin A: a psychotropic terpenoid and divnorin B from the hallucinogenic Mexican mint Salvia divinorum. J Org Chem 49 (1984) 4716-7720
151. Van Heerden F.R., Horak R.M., Maharaj V., Vleggaar R., Senabe J.V., and Gunning P.J. An appetite suppressant from Hoodia species. Phytochemistry 68 (2007) 2545-2553
152. Vermeylen S. Contextualizing 'fair'and 'equitable': the San's reflections on the Hoodia benefit-sharing agreement. Local Environ 12 4 (2007) 423-436
153. Vogl-Lukasser B., and Vogl C.R. Ethnobotanical research in homegardens of small farmers in the alpine region of Osttirol (Austria): an example for bridges built and building bridges. Ethnobot Res Appl 2 (2004) 111-137
154. Volz H.P. Controlled clinical trials of Hypericum extracts in depressed patients - an overview. Pharmacopsychiatry 30 (1997) 72-76
155. Wasson R.G. A new Mexican psychotropic drug from the mint family. Bot Mus Leaf Harv Univ 20 (1962) 77-84
156. Werneke U., Turner T., and Priebe S. Complementary medicines in psychiatry: review of effectiveness and safety. Br J Psychiatry 188 (2006) 109-121
157. Willmore-Fordham C.B., Krall D.M., McCurdy C.R., and Kinder D.H. The hallucinogen derived from Salvia divinorum, salvinorin A, has κ-opioid agonist discriminative stimulus effects in rats. Neuropharmacology 53 (2007) 481-486
158. Wynberg R. Rhetoric, realism and benefit sharing. J World Intellect Prop 7 (2004) 854-876
159. Yuan C.S., Mehendale S., Xiao Y., Aung H.H., Xie J.T., and Ang-Lee M.K. The gamma-aminobutyric acidergic effects of valerian and valeric acid on rat brainstem neuronal activity. Anesth Analg 98 (2004) 353-358
160. Zelger J.L., and Carlini E.A. Influence of cathinone (a-aminopropriophenone) and cathine (phenylpropanolamine) on circling behavior and on the uptake and release of [3H]dopamine in striatal slices of rats. Neuropharmacology 20 (1981) 839-843
161. Zhang W.Y. A benefit-risk assessment of caffeine as an analgesic adjuvant. Drug Saf 24 15 (2001) 1127-1142